Roth R A, Rubin R J
J Pharmacol Exp Ther. 1976 Oct;199(1):61-6.
Rat livers were perfused with a red blood cell-containing perfusion medium. The rate of metabolism of hexobarbital was determined in this system as the recirculating perfusion fluid was made hypoxic by exposure to either CO or lowered oxygen tension. It was found that 7.6% of the total oxygen consumed by the liver was utilized to metabolize hexobarbital regardless of the severity of the hypoxia, which suggests that the liver does not shunt O2 to more preferential pathways as O2 availability becomes limited. When oxygen delivery was lowered below 0.3 ml of O2 per min per g of liver by either type of hypoxia, the rate of hexobarbital metabolism decreased. However, based on the rate of oxygen delivery, CO was more potent than hypoxic hypoxia in inhibiting drug metabolism. On the other hand, the two types of hypoxia were equipotent when compared on the basis of alterations in oxygen consumption. These results are consistent with the known effect of CO in decreasing the availability of hemoglobin-bound O2 and further argue against the direct inhibition of drug metabolism by the binding of CO to cytochrome P-450 in the isolated liver. They also suggest that the lack of a greater potency of CO relative to hypoxic hypoxia in vivo might be related to alterations in hepatic blood flow.
用含红细胞的灌注介质灌注大鼠肝脏。在该系统中,通过将再循环灌注液暴露于一氧化碳(CO)或降低氧张力使其缺氧,来测定己巴比妥的代谢速率。结果发现,无论缺氧的严重程度如何,肝脏消耗的总氧量中有7.6%用于代谢己巴比妥,这表明当氧气供应变得有限时,肝脏不会将氧气分流到更优先的途径。当通过任何一种缺氧方式使肝脏的氧气输送量降低至低于每分钟每克肝脏0.3毫升氧气时,己巴比妥的代谢速率下降。然而,基于氧气输送速率,CO在抑制药物代谢方面比低氧性缺氧更有效。另一方面,在根据耗氧量的变化进行比较时,这两种缺氧方式的效力相当。这些结果与已知的CO降低血红蛋白结合氧可用性的作用一致,并且进一步反驳了在离体肝脏中CO与细胞色素P - 450结合直接抑制药物代谢的观点。它们还表明,在体内CO相对于低氧性缺氧缺乏更大效力可能与肝血流量的改变有关。